Back Androgeenongevoeligheidsindroom Afrikaans متلازمة عدم الحساسية للأندروجين Arabic Sindrom neosjetljivosti na androgen BS Síndrome d’insensibilitat androgènica Catalan Androgenresistenz German Síndrome de insensibilidad a los andrógenos Spanish Androgeenresistentsuse sündroom Estonian سندروم بیحساسیتی آندروژن Persian Androgeeni-insensitiivisyyssyndrooma Finnish Syndrome d'insensibilité aux androgènes French
| Androgen insensitivity syndrome | |
|---|---|
 | |
| AIS results when the function of the androgen receptor (AR) is impaired. The AR protein (pictured) mediates the effects of androgens in the human body. | |
| Specialty | Endocrinology |
Androgen insensitivity syndrome (AIS) is a condition involving the inability to respond to androgens, typically due to androgen receptor dysfunction.[1]
It affects 1 in 20,000 to 64,000 XY (karyotypically male) births. The condition results in the partial or complete inability of cells to respond to androgens.[2] This unresponsiveness can impair or prevent the development of male genitals, as well as impairing or preventing the development of male secondary sexual characteristics at puberty. It does not significantly impair female genital or sexual development.[3][4] The insensitivity to androgens is therefore clinically significant only when it occurs in genetic males, (i.e. individuals with a Y-chromosome, or more specifically, an SRY gene).[5] Clinical phenotypes in these individuals range from a typical male habitus with mild spermatogenic defect or reduced secondary terminal hair, to a full female habitus, despite the presence of a Y-chromosome.[6]
AIS is divided into three categories that are differentiated by the degree of genital masculinization:
- Mild androgen insensitivity syndrome (MAIS) is indicated when the external genitalia are those of a typical male (a penis and a scrotum)
- Partial androgen insensitivity syndrome (PAIS) is indicated when the external genitalia are partially, but not fully, masculinized[7][8]
- Complete androgen insensitivity syndrome (CAIS) is indicated when the external genitalia are those of a typical female (a vulva)
Androgen insensitivity syndrome is the largest single entity that leads to 46,XY undermasculinized genitalia.[9]
Management of AIS is currently limited to symptomatic management; no method is currently available to correct the malfunctioning androgen receptor proteins produced by AR gene mutations. Areas of management include sex assignment, genitoplasty, gonadectomy to reduce tumor risk, hormone replacement therapy, genetic counseling, and psychological counseling.
- ^ Legato, Marianne J. (2017-05-15). Principles of Gender-Specific Medicine: Gender in the Genomic Era. Academic Press. p. 34. ISBN 978-0-12-803542-9.
- ^ Cite error: The named reference
lead:1was invoked but never defined (see the help page). - ^ Cite error: The named reference
1995 quigley 16was invoked but never defined (see the help page). - ^ Cite error: The named reference
2002 giwercman 87was invoked but never defined (see the help page). - ^ Cite error: The named reference
2006 hughes 20was invoked but never defined (see the help page). - ^ Cite error: The named reference
lead:2was invoked but never defined (see the help page). - ^ Cite error: The named reference
lead:3was invoked but never defined (see the help page). - ^ Cite error: The named reference
lead:4was invoked but never defined (see the help page). - ^ Cite error: The named reference
1999 ahmed 80was invoked but never defined (see the help page).
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search